Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products

M Ibrahim, E Ramadan, NE Elsadek, SE Emam… - Journal of Controlled …, 2022 - Elsevier
Polyethylene glycol (PEG) is a versatile polymer that is widely used as an additive in foods
and cosmetics, and as a carrier in PEGylated therapeutics. Even though PEG is thought to …

Advances in oral drug delivery

MS Alqahtani, M Kazi, MA Alsenaidy… - Frontiers in …, 2021 - frontiersin.org
The oral route is the most common route for drug administration. It is the most preferred
route, due to its advantages, such as non-invasiveness, patient compliance and …

Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications

AA D'souza, R Shegokar - Expert opinion on drug delivery, 2016 - Taylor & Francis
Introduction: Polyethylene glycol (PEG) is a polymer of choice in drug delivery systems. This
USFDA-approved polymer is popular due to its tunable properties and well-established …

Oral delivery of anticancer drugs: challenges and opportunities

K Thanki, RP Gangwal, AT Sangamwar… - Journal of controlled …, 2013 - Elsevier
The present report focuses on the various aspects of oral delivery of anticancer drugs. The
significance of oral delivery in cancer therapeutics has been highlighted which principally …

Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery

ZS Bayindir, N Yuksel - Journal of pharmaceutical sciences, 2010 - Elsevier
Nonionic surfactant based vesicles (niosomes) are novel drug delivery systems formed from
the self‐assembly of nonionic amphiphiles in aqueous media. In the present study niosomal …

Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis

E Roger, F Lagarce, E Garcion, JP Benoit - Journal of controlled release, 2009 - Elsevier
The use of lipid nanocapsules (LNCs) has enabled an improvement of the oral
bioavailability of paclitaxel (Ptx). However, mechanisms that support this recent observation …

Paclitaxel drug delivery systems

Z Zhang, L Mei, SS Feng - Expert opinion on drug delivery, 2013 - Taylor & Francis
Introduction: Paclitaxel (PTX) is one of the most effective broad-spectrum chemotherapeutic
agents in the treatment of cancers. However, its clinical application has been limited due to …

[HTML][HTML] Chemoresistance and chemosensitization in cholangiocarcinoma

JJG Marin, E Lozano, E Herraez, M Asensio… - … et Biophysica Acta (BBA …, 2018 - Elsevier
One of the main difficulties in the management of patients with advanced
cholangiocarcinoma (CCA) is their poor response to available chemotherapy. This is the …

Natural and synthetic polymers as inhibitors of drug efflux pumps

M Werle - Pharmaceutical Research, 2008 - Springer
Inhibition of efflux pumps is an emerging approach in cancer therapy and drug delivery.
Since it has been discovered that polymeric pharmaceutical excipients such as Tweens® or …

Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation

T Bansal, N Akhtar, M Jaggi, RK Khar… - Drug discovery today, 2009 - Elsevier
Considerable research efforts have been directed towards understanding the enigma of P-
glycoprotein (P-gp) in drug development and delivery. P-gp is a multi-specific drug efflux …